Showing results (251-260 of 271) with videos related to
Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2D Gareth Evans, Michel Kalamarides, Kim Hunter-Schaedle, et al.Neuro-Oncology Practice|July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiativeLinda Dirven, Maartje E Vos, Tobias Walbert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor MicroenvironmentLindy Zhang, Alexandre Maalouf, Stavriani C Makri, et al.Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.Journal of Pediatric Orthopedics|May 30, 2023
Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical TherapyAmy L Xu, Krishna V Suresh, Jaime A Gomez, et al.Nature Genetics|December 24, 2013
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomasArkadiusz Piotrowski, Jing Xie, Ying F Liu, et al.Neuro-Oncology|January 14, 2025
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial DesignRupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, et al.The New England Journal of Medicine|March 19, 2020
Selumetinib in Children with Inoperable Plexiform NeurofibromasAndrea M Gross, Pamela L Wolters, Eva Dombi, et al.Ophthalmology and Therapy|January 23, 2026
A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea® in Patients with Wet Age-Related Macular DegenerationMudit Bansal, Punit Singh, Ruchi K Mehta, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2021
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendationEric Legius, Ludwine Messiaen, Pierre Wolkenstein, et al.Pageof 28